Skip to content
OpenCapital
Get started

Nuvectis Pharma, Inc. NVCT Market capitalization

Market capitalization at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$123.83B-0.2%
Pfizer logo
PfizerPFE
$159.73B+11.1%
Immix Biopharma, Inc. logo
Immix Biopharma, Inc.IMMX
$482.51M+936%
Relmada Therapeutics, Inc. logo
Relmada Therapeutics, Inc.RLMD
$730.04M+8,046%
Nuvation Bio logo
Nuvation BioNUVB
$1.49B+150%
Immunome logo
ImmunomeIMNM
$2.47B+323%

Other financials

Income statement

See full
Operating income-$6.3M-12.4%
Net income-$6.1M-13.5%
EPS (diluted)-$0.26+3.7%

Balance sheet

See full
Cash & equivalents$25.1M-15.9%
Total equity$14.2M-32.1%
Total assets$25.4M-15.8%

Cash flow

See full
Operating cash flow-$6.5M-56.0%

Returns & leverage

See full
Return on equity-154.4%+79.4pp
Current ratio2.3×-1.0×

Where this comes from

Computed from the period-end share price: $204.78M.

The official record: Nuvectis Pharma, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvectis Pharma, Inc.'s market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nuvectis Pharma, Inc.'s market capitalization?
Nuvectis Pharma, Inc. (NVCT) reported market capitalization of $204.78M in Q1 2026.
How has Nuvectis Pharma, Inc.'s market capitalization changed year-over-year?
Nuvectis Pharma, Inc.'s market capitalization decreased by 10.4% year-over-year, from $228.53M to $204.78M.
What is the long-term trend for Nuvectis Pharma, Inc.'s market capitalization?
Over 3 years (2022 to 2025), Nuvectis Pharma, Inc.'s market capitalization has grown at a 20.8% compound annual growth rate (CAGR), from $109.82M to $193.39M.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.